Connection

Luke Moore to Pneumonia, Viral

This is a "connection" page, showing publications Luke Moore has written about Pneumonia, Viral.
Connection Strength

0.116
  1. Comparison of deep learning with regression analysis in creating predictive models for SARS-CoV-2 outcomes. BMC Med Inform Decis Mak. 2020 11 19; 20(1):299.
    View in: PubMed
    Score: 0.029
  2. Serological assays for delayed SARS-CoV-2 case identification - Author's reply. Lancet Respir Med. 2020 10; 8(10):e74.
    View in: PubMed
    Score: 0.029
  3. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020 Oct; 26(10):1395-1399.
    View in: PubMed
    Score: 0.028
  4. Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care population. PLoS One. 2020; 15(10):e0240960.
    View in: PubMed
    Score: 0.007
  5. Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation. Circulation. 2020 11 03; 142(18):1791-1793.
    View in: PubMed
    Score: 0.007
  6. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study. Lancet Respir Med. 2020 09; 8(9):885-894.
    View in: PubMed
    Score: 0.007
  7. COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother. 2020 07 01; 75(7):1681-1684.
    View in: PubMed
    Score: 0.007
  8. Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol. 2020 08; 18(8):409-410.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.